Caterina Brighi

Dr. Caterina Brighi

University of Sydney, Sydney, New South Wales, Australia
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2022 in Nature Reviews Clinical Oncology
Verified
Journal Article
Closed access
PDF file
PKPaul J. Keall
Paul J. Keall
CBCaterina Brighi
Caterina Brighi
CGCarri Glide-Hurst
Carri Glide-Hurst
GLGary Liney
Gary Liney
PLPaul Z. Y. Liu
Paul Z. Y. Liu
BWBrendan Whelan
Brendan Whelan

7 December 2016 in Nature Communications
Verified
Journal Article
Open access
JDJulia M. Diaz
Julia M. Diaz
CHColleen Hansel
Colleen Hansel
Amy ApprillAmy Apprill
Amy Apprill
CBCaterina Brighi
Caterina Brighi
TZTong Zhang
Tong Zhang
LXLiping Xun
Liping Xun
The reactive oxygen species superoxide (O2·−) is both beneficial and detrimental to life. Within corals, superoxide may contribute to pathogen resistance but also bleaching, the loss of essential algal symbionts. Yet, the role of superoxide in coral health and physiology is not completely understood owing to a lack of direct in situ observations. By conducting field measurements of superoxide produced by corals during a bleaching event, we show substantial species-specific variation in external superoxide levels, which reflect the balance of production and degradation processes. Extracellular superoxide concentrations are independent of light, algal symbiont abundance and bleaching status, but depend on coral species and bacterial community composition. Furthermore, coral-derived superoxide concentrations ranged from levels below bulk seawater up to ∼120 nM, some of the highest superoxide concentrations observed in marine systems. Overall, these results unveil the ability of corals and/or their microbiomes to regulate superoxide in their immediate surroundings, which suggests species-specific roles of superoxide in coral health and physiology.

23 March 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
CBCaterina Brighi
Caterina Brighi
ESEkaterina Salimova
Ekaterina Salimova
MVMichael de Veer
Michael de Veer
SPSimon Puttick
Simon Puttick
GEGary F Egan
Gary F Egan

5 March 2022 in Radiotherapy and Oncology
Verified
Journal Article
Open access
TPTrang Thanh Pham
Trang Thanh Pham
BWBrendan Whelan
Brendan Whelan
BOBradley M. Oborn
Bradley M. Oborn
GDGeoff P. Delaney
Geoff P. Delaney
SVShalini Vinod
Shalini Vinod
PKPaul Keall
Paul Keall
Proton therapy and MRI-Linacs are two of the most exciting and fast growing technologies in radiation oncology. With over 100 MRI-Linacs and 100 proton therapy centres either in operation or under construction, an integrated approach that brings together the excellent soft tissue imaging of MRI with the superior dose conformity of proton therapy is compelling. The promise of MRI-guided proton therapy has prompted multiple research studies and the building of two pre-clinical experimental systems, taking us closer to realisation of this technology. Patients who would benefit most are those whose cancers have substantial tumour motion or anatomical variation, and those who are currently unable to receive safe dose-escalation due to nearby critical structures. MRI-guided proton therapy could allow more patients with pancreatic cancer, central lung cancer and oligo-metastatic cancers in the upper abdomen (e.g. liver and adrenal) to safely receive escalated curative doses. Head and neck, lung, brain and cervix cancers, where treatment accuracy is affected by inter-fraction tumour changes such as tumour regression or changing oedema, or normal anatomy variations, would also benefit from MRI-guidance. There will be new options to improve cure by functional MRI-guided biologically adapted proton therapy. This review focuses on the clinical aspects of MRI-guided proton therapy. We describe the clinical challenges in proton therapy and the clinical benefits from the addition of MRI-guidance. We provide updates on the design and beam modelling of in-line and perpendicular MRI-guided proton therapy systems, and a roadmap to clinical implementation.

1 January 2020 in Theranostics
Verified
Journal Article
Open access
CBCaterina Brighi
Caterina Brighi
LRLee Reid
Lee Reid
LGLaura A Genovesi
Laura A Genovesi
MKMarija Kojic
Marija Kojic
AMAmanda Millar
Amanda Millar
SPSimon Puttick
Simon Puttick
The clinical translation of new nanoparticle-based therapies for high-grade glioma (HGG) remains extremely poor. This has partly been due to the lack of suitable preclinical mouse models capable of replicating the complex characteristics of recurrent HGG (rHGG), namely the heterogeneous structural and functional characteristics of the blood-brain barrier (BBB). The goal of this study is to compare the characteristics of the tumor BBB of rHGG with two different mouse models of HGG, the ubiquitously used U87 cell line xenograft model and a patient-derived cell line WK1 xenograft model, in order to assess their suitability for nanomedicine research.

24 November 2016 in Frontiers in Marine Science
Verified
Journal Article
Open access
PDF file
TZTong Zhang
Tong Zhang
JDJulia M. Diaz
Julia M. Diaz
CBCaterina Brighi
Caterina Brighi
RPRachel J. Parsons
Rachel J. Parsons
SMSean McNally
Sean McNally
CHColleen Hansel
Colleen Hansel
The reactive oxygen species (ROS) superoxide has been implicated in both beneficial and detrimental processes in coral biology, ranging from pathogenic disease resistance to coral bleaching. Despite the critical role of ROS in coral health, there is a distinct lack of ROS measurements and thus an incomplete understanding of underpinning ROS sources and production mechanisms within coral systems. Here, we quantified in situ extracellular superoxide concentrations at the surfaces of aquaria-hosted Porites astreoides during a diel cycle. High concentrations of superoxide (~10’s of nM) were present at coral surfaces, and these levels did not change significantly as a function of time of day. These results indicate that the coral holobiont produces extracellular superoxide in the dark, independent of photosynthesis. As a short-lived anion at physiological pH, superoxide has a limited ability to cross intact biological membranes. Further, removing surface mucus layers from the P. astreoides colonies did not impact external superoxide concentrations. We therefore attribute external superoxide derived from the coral holobiont under these conditions to the activity of the coral host epithelium, rather than mucus-derived epibionts or internal sources such as endosymbionts (e.g., Symbiodinium). However, endosymbionts likely contribute to internal ROS levels via extracellular superoxide production. Indeed, common coral symbionts, including multiple strains of Symbiodinium (clades A to D) and the bacterium Endozoicomonas montiporae LMG 24815, produced extracellular superoxide in the dark and at low light levels. Further, representative P. astreoides symbionts, Symbiodinium CCMP2456 (clade A) and E. montiporae, produced similar concentrations of superoxide alone and in combination with each other, in the dark and low light, and regardless of time of day. Overall, these results indicate that healthy, non-stressed P. astreoides and representative symbionts produce superoxide externally, which is decoupled from photosynthetic activity and circadian control. Corals may therefore produce extracellular superoxide constitutively, highlighting an unclear yet potentially beneficial role for superoxide in coral physiology and health.